Eli Lilly and (LLY) insider buying

Healthcare · Drug Manufacturers - General · Market cap $1.08T

24 open-market purchases of LLY by Eli Lilly and's executives and directors since August 2025, worth $0 in total, from SEC Form 4 filings.

The most recent: David Taylor bought — on February 26, 2026.

The biggest buyer over the period is David Taylor: 6 purchases, $0.

By year

YearPurchasesValue
20266$0
202518$0

Biggest buyers

InsiderBuysValue
David Taylor
6$0
Ro Khanna
3$0
Markwayne Mullin
3$0
Angus S. King Jr.
3$0
Gilbert Ray Cisneros, Jr.
3$0
Shelley Moore Capito
3$0
John Boozman
3$0

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Feb 26, 2026 David Taylor
0$1,022.16— —
Feb 26, 2026 David Taylor
0$1,022.16— —
Feb 26, 2026 David Taylor
0$1,022.16— —
Jan 23, 2026 Ro Khanna
0$1,065.05— —
Jan 23, 2026 Ro Khanna
0$1,065.05— —
Jan 23, 2026 Ro Khanna
0$1,065.05— —
Dec 29, 2025 Markwayne Mullin
0$1,078.72— —
Dec 29, 2025 Angus S. King Jr.
0$1,078.72— —
Dec 29, 2025 Markwayne Mullin
0$1,078.72— —
Dec 29, 2025 Markwayne Mullin
0$1,078.72— —
Dec 29, 2025 Angus S. King Jr.
0$1,078.72— —
Dec 29, 2025 Angus S. King Jr.
0$1,078.72— —
Nov 18, 2025 Gilbert Ray Cisneros, Jr.
0$1,030.49— —
Nov 18, 2025 Gilbert Ray Cisneros, Jr.
0$1,030.49— —
Nov 18, 2025 Gilbert Ray Cisneros, Jr.
0$1,030.49— —
Oct 24, 2025 Shelley Moore Capito
0$825.86— —
Oct 24, 2025 Shelley Moore Capito
0$825.86— —
Oct 24, 2025 Shelley Moore Capito
0$825.86— —
Aug 22, 2025 John Boozman
0$710.73— —
Aug 22, 2025 John Boozman
0$710.73— —
Aug 22, 2025 John Boozman
0$710.73— —
Aug 14, 2025 David Taylor
0$685.27— —
Aug 14, 2025 David Taylor
0$685.27— —
Aug 14, 2025 David Taylor
0$685.27— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for LLY.
Open LLY in Investingly

Questions

Are Eli Lilly and insiders buying the stock?

24 open-market purchases of LLY by Eli Lilly and's executives and directors since August 2025, worth $0 in total, from SEC Form 4 filings. The most recent: David Taylor bought — on February 26, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Eli Lilly and's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.